Small-aperture intraocular lens
Colin Kerr
Published: Friday, December 7, 2018
AcuFocus has received approval for an Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA) to conduct a study of its IC-8 small-aperture intraocular lens (IOL).
The IC-8 IOL is a clear monofocal lens with an embedded mini-ring or pinhole in the centre. It is designed to increase a patient’s natural range of vision by extending the focus of light rays that enter the eye.
“Achieving IDE approval was the next milestone as we seek premarket approval in the US,” said Al Waterhouse, AcuFocus Chief Executive Officer.
http://www.acufocus.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.